Pharmacokinetics of Total and Unbound Etravirine in HIV-1-Infected Pregnant Women.


BACKGROUND Treatment of HIV-1-infected women during pregnancy protects maternal health and reduces the risk of perinatal transmission of HIV-1. However, physiologic changes that occur during pregnancy may affect drug pharmacokinetics. This phase IIIb, open-label study evaluated the effects of pregnancy on the pharmacokinetics of the nonnucleoside reverse… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.